In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Incyte Corporation
TuHURA Biosciences, Inc.
Fujifilm Pharmaceuticals U.S.A., Inc.
Memgen, Inc.
Pfizer
University of Virginia
Incyte Corporation